Louise Stone - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Louise Stone's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Louise Stone

Louise Stone

Verified

Senior Editor, Nature Reviews Urology

Final Covers

Health and Social Affairs

Doesn’t Cover

extreme sports

Journalist Type

-

Seniority Positions

Industries

Medium Formats

-

Content

Total articles 74

  • Bladder-sparing neoadjuvant therapy for MIBC - Nature Reviews Urology

    By Louise Stone| Nature Verified Patients with muscle-invasive bladder cancer (MIBC) could avoid undergoing radical cystectomy (the current standard-of-care treatment) and its associated morbidity if they achieve a clinical complete response (cCR) on neoadjuvant combination treatment consisting of four cycles of gemcitabine, cisplatin and nivolumab.

    By Louise Stone · Nature

    Nov. 01, 2023

  • Doctors are being sexually harassed at work. This needs to stop

    By Louise Stone| The Conversation Verified Dominique Lee was training in radiation oncology when she was invited to join her supervisor to discuss a training opportunity. Instead, she was drugged and sexually assaulted. Lee reported the crime, and John Kearsley was sentenced two years later. Kearsley has since been sentenced for another sexual assault against the daughter of a patient. For Lee, the impact of that assault has been profound. “It’s taken almost ten years to look at myself in the mirror and not feel shame and hate,” she says.

    By Louise Stone · The Conversation

    Oct. 24, 2023

  • Bladder-sparing neoadjuvant therapy for MIBC - Nature Reviews Urology

    By Louise Stone| Nature Verified Patients with muscle-invasive bladder cancer (MIBC) could avoid undergoing radical cystectomy (the current standard-of-care treatment) and its associated morbidity if they achieve a clinical complete response (cCR) on neoadjuvant combination treatment consisting of four cycles of gemcitabine, cisplatin and nivolumab.

    By Louise Stone · Nature

    Nov. 01, 2023

As seen in

Company Info

Nature Reviews Urology

London, England, United Kingdom

+44 20 7833 4000